Therapy Area
Exeliom to focus on gastric cancer landscape with immune modulating drug
Exeliom is running three Phase II trials of the candidate in three oncology indications but will focus on the gastric cancer approval route.
“Intentional effort” needed from sponsors to achieve diversity in oncology clinical trials
World Immunization Week 2024: mRNA vaccines hold potential in multiple disease areas
Novartis and MMV’s Coartem shows promise in infants with Phase II/III data
Alzheimer’s trial doses patients with stem cell treatment directly to brain
Hanmi signs clinical trial collaboration with MSD
